Q3 2023 Holdings
Filed 2023-11-09 | 12 holdings | $44.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Centessa Pharmaceuticals plc(CNTA) | Sponsored ADS | 152309100 | $19.0M | 2,937,615 | 42.7% |
| Aerovate Therapeutics Inc. | Common Stock | 008064107 | $8.2M | 603,762 | 18.4% |
| Cyteir Therapeutics, Inc. | Common Stock | 23284P103 | $7.0M | 2,459,572 | 15.7% |
| PMV Pharmaceuticals, Inc.(PMVP) | Common Stock | 69353Y103 | $6.1M | 989,232 | 13.7% |
| Graphite Bio(GRPH) | Common Stock | 38870X104 | $1.0M | 406,308 | 2.3% |
| Selecta Biosciences, Inc.(SELBUSD) | Common Stock | 816212104 | $914.3K | 862,543 | 2.1% |
| Vor Biopharma Inc. | Common Stock | 929033108 | $794.4K | 374,714 | 1.8% |
| eFFECTOR Therapeutics, Inc. | Common Stock | 28202V108 | $615.3K | 1,025,697 | 1.4% |
| Precision BioSciences, Inc. | Common Stock | 74019P108 | $383.6K | 1,123,913 | 0.9% |
| Spero Therapeutics, Inc.(SPRO) | Common Stock | 84833T103 | $301.4K | 249,070 | 0.7% |
| Ikena Oncology, Inc. | Common Stock | 45175G108 | $116.2K | 26,833 | 0.3% |
| Homology Medicines, Inc. | Common Stock | 438083107 | $74.9K | 64,000 | 0.2% |